186 related articles for article (PubMed ID: 36307407)
1. Chemical space docking enables large-scale structure-based virtual screening to discover ROCK1 kinase inhibitors.
Beroza P; Crawford JJ; Ganichkin O; Gendelev L; Harris SF; Klein R; Miu A; Steinbacher S; Klingler FM; Lemmen C
Nat Commun; 2022 Oct; 13(1):6447. PubMed ID: 36307407
[TBL] [Abstract][Full Text] [Related]
2. Development and evaluation of an integrated virtual screening strategy by combining molecular docking and pharmacophore searching based on multiple protein structures.
Tian S; Sun H; Li Y; Pan P; Li D; Hou T
J Chem Inf Model; 2013 Oct; 53(10):2743-56. PubMed ID: 24010823
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel CK2 leads by cross-docking based virtual screening.
Sun H; Wu X; Xu X; Jiang Z; Liu Z; You Q
Med Chem; 2014; 10(6):628-39. PubMed ID: 24286395
[TBL] [Abstract][Full Text] [Related]
4. Synthon-based ligand discovery in virtual libraries of over 11 billion compounds.
Sadybekov AA; Sadybekov AV; Liu Y; Iliopoulos-Tsoutsouvas C; Huang XP; Pickett J; Houser B; Patel N; Tran NK; Tong F; Zvonok N; Jain MK; Savych O; Radchenko DS; Nikas SP; Petasis NA; Moroz YS; Roth BL; Makriyannis A; Katritch V
Nature; 2022 Jan; 601(7893):452-459. PubMed ID: 34912117
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Rho-kinase inhibitors by docking-based virtual screening.
Shen M; Yu H; Li Y; Li P; Pan P; Zhou S; Zhang L; Li S; Lee SM; Hou T
Mol Biosyst; 2013 Jun; 9(6):1511-21. PubMed ID: 23549429
[TBL] [Abstract][Full Text] [Related]
6. Pharmacophore modeling and virtual screening in search of novel Bruton's tyrosine kinase inhibitors.
Sharma A; Thelma BK
J Mol Model; 2019 Jun; 25(7):179. PubMed ID: 31172362
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the predictivity of virtual screening for ABL kinase inhibitors to hinder drug resistance.
Gani OA; Narayanan D; Engh RA
Chem Biol Drug Des; 2013 Nov; 82(5):506-19. PubMed ID: 23746052
[TBL] [Abstract][Full Text] [Related]
8. Covalent docking of large libraries for the discovery of chemical probes.
London N; Miller RM; Krishnan S; Uchida K; Irwin JJ; Eidam O; Gibold L; Cimermančič P; Bonnet R; Shoichet BK; Taunton J
Nat Chem Biol; 2014 Dec; 10(12):1066-72. PubMed ID: 25344815
[TBL] [Abstract][Full Text] [Related]
9. An Integrated In Silico Method to Discover Novel Rock1 Inhibitors: Multi- Complex-Based Pharmacophore, Molecular Dynamics Simulation and Hybrid Protocol Virtual Screening.
Chen H; Li S; Hu Y; Chen G; Jiang Q; Tong R; Zang Z; Cai L
Comb Chem High Throughput Screen; 2016; 19(1):36-50. PubMed ID: 26632439
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of using molecular docking-based virtual screening for searching dual target kinase inhibitors.
Zhou S; Li Y; Hou T
J Chem Inf Model; 2013 Apr; 53(4):982-96. PubMed ID: 23506306
[TBL] [Abstract][Full Text] [Related]
11. Fragment-Based Discovery and Optimization of Enzyme Inhibitors by Docking of Commercial Chemical Space.
Rudling A; Gustafsson R; Almlöf I; Homan E; Scobie M; Warpman Berglund U; Helleday T; Stenmark P; Carlsson J
J Med Chem; 2017 Oct; 60(19):8160-8169. PubMed ID: 28929756
[TBL] [Abstract][Full Text] [Related]
12. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
[TBL] [Abstract][Full Text] [Related]
13. Artificial intelligence-enabled virtual screening of ultra-large chemical libraries with deep docking.
Gentile F; Yaacoub JC; Gleave J; Fernandez M; Ton AT; Ban F; Stern A; Cherkasov A
Nat Protoc; 2022 Mar; 17(3):672-697. PubMed ID: 35121854
[TBL] [Abstract][Full Text] [Related]
14. Investigation of Crystal Structures in Structure-Based Virtual Screening for Protein Kinase Inhibitors.
Chen X; Liu H; Xie W; Yang Y; Wang Y; Fan Y; Hua Y; Zhu L; Zhao J; Lu T; Chen Y; Zhang Y
J Chem Inf Model; 2019 Dec; 59(12):5244-5262. PubMed ID: 31689093
[TBL] [Abstract][Full Text] [Related]
15. Structure-Based Virtual Screening for Ligands of G Protein-Coupled Receptors: What Can Molecular Docking Do for You?
Ballante F; Kooistra AJ; Kampen S; de Graaf C; Carlsson J
Pharmacol Rev; 2021 Oct; 73(4):527-565. PubMed ID: 34907092
[TBL] [Abstract][Full Text] [Related]
16. An in silico high-throughput screen identifies potential selective inhibitors for the non-receptor tyrosine kinase Pyk2.
Meirson T; Samson AO; Gil-Henn H
Drug Des Devel Ther; 2017; 11():1535-1557. PubMed ID: 28572720
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
18. HIt Discovery using docking ENriched by GEnerative Modeling (HIDDEN GEM): A novel computational workflow for accelerated virtual screening of ultra-large chemical libraries.
Popov KI; Wellnitz J; Maxfield T; Tropsha A
Mol Inform; 2024 Jan; 43(1):e202300207. PubMed ID: 37802967
[TBL] [Abstract][Full Text] [Related]
19. Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations.
Zhang Y; Zhang TJ; Tu S; Zhang ZH; Meng FH
Molecules; 2020 Sep; 25(18):. PubMed ID: 32911607
[TBL] [Abstract][Full Text] [Related]
20. Scoring of KDR kinase inhibitors: using interaction energy as a guide for ranking.
McGaughey GB; Culberson JC; Feuston BP; Kreatsoulas C; Maiorov V; Shpungin J
Mol Divers; 2006 Aug; 10(3):341-7. PubMed ID: 17004013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
